You'll be hearing about Project ImPACT

You'll be hearing about Project ImPACT...a two-year study to show how pharmacists can improve compliance in patients on cholesterol-lowering therapy.

It's being conducted by APhA and funded by Merck.

Pharmacists will use a nifty Cholestech machine. It determines cholesterol levels from a fingerstick blood sample...then calculates the patient's risk of developing coronary heart disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote